Evaluating incremental values from new predictors with net reclassification improvement in survival analysis
暂无分享,去创建一个
Yingye Zheng | Tianxi Cai | Layla Parast | Marshall Brown | T. Cai | Layla Parast | Yingye Zheng | Marshall D. Brown
[1] R. Tibshirani,et al. Improvements on Cross-Validation: The 632+ Bootstrap Method , 1997 .
[2] D. Lloyd‐Jones,et al. Cardiovascular risk prediction: basic concepts, current status, and future directions. , 2010, Circulation.
[3] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[4] Jisheng Cui,et al. Overview of risk prediction models in cardiovascular disease research. , 2009, Annals of epidemiology.
[5] L. J. Wei,et al. The Robust Inference for the Cox Proportional Hazards Model , 1989 .
[6] Allen J. Taylor,et al. The Framingham Risk Score: an appraisal of its benefits and limitations. , 2007, The American heart hospital journal.
[7] R. Gill,et al. Cox's regression model for counting processes: a large sample study : (preprint) , 1982 .
[8] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[9] E. Topol,et al. Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease , 2003 .
[10] Hajime Uno,et al. Calibrating parametric subject-specific risk estimation. , 2010, Biometrika.
[11] Lu Tian,et al. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data , 2013, Statistics in medicine.
[12] Els Goetghebeur,et al. Model evaluation based on the sampling distribution of estimated absolute prediction error , 2007 .
[13] Tianxi Cai,et al. Evaluating Prediction Rules for t-Year Survivors With Censored Regression Models , 2007 .
[14] Nancy R Cook,et al. The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women , 2006, Annals of Internal Medicine.
[15] Somnath Datta,et al. The Kaplan–Meier Estimator as an Inverse-Probability-of-Censoring Weighted Average , 2001, The American statistician.
[16] Margaret Pepe,et al. Measures to Summarize and Compare the Predictive Capacity of Markers , 2009, The international journal of biostatistics.
[17] W. Kannel,et al. An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.
[18] Nils Lid Hjort,et al. On inference in parametric survival data models , 1992 .
[19] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[20] Tianxi Cai,et al. Comparing Risk Scoring Systems Beyond the ROC Paradigm in Survival Analysis , 2009 .
[21] Tianxi Cai,et al. Time-Dependent Predictive Values of Prognostic Biomarkers With Failure Time Outcome , 2008, Journal of the American Statistical Association.
[22] D. Pollard. Empirical Processes: Theory and Applications , 1990 .
[23] Ewout W Steyerberg,et al. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.
[24] Zhiliang Ying,et al. Towards a general asymptotic theory for Cox model with staggered entry , 1997 .
[25] Dorota M. Dabrowska,et al. Smoothed Cox regression , 1997 .
[26] N. Cook. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.